Last reviewed · How we verify
NCT07376473: MenQOL 2
Psychometric Validation of the MQOL-FR and Descriptive Assessment of Quality of Life in Patients With Meningiomas
trial testing Quality-of-life questionnaire administration in Intracranial Meningioma in 238 participants. Not yet recruiting.
2 September 2026
Quick facts
| Lead sponsor | Centre Hospitalier St Anne |
|---|---|
| Status | Not yet recruiting |
| Study type | OBSERVATIONAL |
| Enrollment | 238 |
| Start date | 2 February 2026 |
| Primary completion | 2 September 2026 |
| Estimated completion | 2 September 2026 |
Drugs / interventions tested
- Quality-of-life questionnaire administration
Conditions studied
- Intracranial Meningioma — all drugs for Intracranial Meningioma →
- Meningioma — all drugs for Meningioma →
- Health-related Quality of Life — all drugs for Health-related Quality of Life →
Sponsor
Centre Hospitalier St Anne
Who can join
Adults 18 to 60, any sex, with Intracranial Meningioma or Meningioma. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This non-interventional study aims to validate the French version of a meningioma-specific quality-of-life questionnaire (MQOL-FR) and to describe health-related quality of life in adults diagnosed with an intracranial meningioma. Participants will be invited to complete online questionnaires through a secure REDCap link. After reading the study information and recording their non-opposition, participants will complete: (1) MQOL-FR (meningioma-specific), (2) EQ-5D-5L (generic health-related quality of life), and (3) FACT-Br (brain tumor-specific quality of life). The questionnaire session takes approximately 30-45 minutes and can be completed in more than one sitting using a REDCap access code. There is no additional visit and no change in usual care. The study will recruit adults (≥18 years) with a meningioma diagnosis based on imaging and/or confirmed by surgery, through the GHU Paris-Sainte-Anne neurosurgery clinic and through patient/community networks. The goal is to obtain 100 fully completed MQOL-FR questionnaires suitable for psychometric analyses.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07376473
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Intracranial Meningioma
Currently open trials in the same condition.
- NCT03180268 — Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely · Phase 3 · recruiting
Other Centre Hospitalier St Anne trials
Trials by the same sponsor.
- NCT07340736 — Sensory Mechanisms of Manual Dexterity Recovery After Stroke: a Prospective Cohort Study of Prediction and Cerebral Corr · NA · not yet recruiting
- NCT07395323 — Impact of Relaxation Sessions Using a Virtual Reality Application on the Sleep Quality of Caregivers Working Night Shift · NA · not yet recruiting
- NCT07283458 — Assessment of Language Comprehension and Learning in Children Attending Child Psychiatry Services (TICOALA-SOINS) · NA · not yet recruiting
- NCT07144956 — Cilostazol With Nimodipine to Improve Outcome After Aneurysmal Subarachnoid Hemorrhage · Phase 3 · not yet recruiting
- NCT07168447 — Transfusion Exchanges and Cognition in Sickle Cell Disease · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07376473 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Centre Hospitalier St Anne
- Last refreshed: 3 February 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07376473.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing